Mersana

Mersana's Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research Meeting

...e variety of angiogenic tumors," said Julie Olson, mersana CEO. "Earlier drugs in this class showed promisin...ivity reported in a separate poster. About mersana Therapeutics, Inc. Mersana, a privately held, v...visit www.mersana.com . Fleximer and mersana (R) are trademarks of ...

Mersana in Medical Technology

Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference

...h concentrations in tumor tissue. About Fleximer mersana is transforming oncology product development by cr... significantly improving toxicity profiles. About mersana Therapeutics, Inc. Mersana, a privately held, ven...and PureTech Ventures. Fleximer is a trademark of mersana Therapeutics, Inc. ...

Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001 at American Association of Cancer Research Annual Meeting

...onditions, and non-enzymatic biodegradability upon uptake by cells. About mersana Therapeutics, Inc. Mersana, a privately held, venture-backed company, is ...terial that enhances the pharmacokinetics, safety, and solubility of drugs. mersana has an exclusive license from the Massachusetts General Hospital for its co...

Mersana in Biological Technology

Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors

...rs - CAMBRIDGE, Mass., June 1 /PRNewswire/ -- mersana Therapeutics presented preliminary results of a Ph...; TGen Clinical Research Services, Scottsdale, AZ; mersana Therapeutics, Inc., Cambridge, MA; Covance Bioanal...y in common manufacturing procedures. About mersana Therapeutics, Inc. ...

Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.

.... "We are thrilled that Tim is now a part of the mersana team," said Julie A. Olson, President and CEO at M... of British Columbia in Vancouver, Canada. About mersana Therapeutics, Inc. Mersana, a privately held, ve...PureTech Ventures. Fleximer(R) is a trademark of mersana Therapeutics, Inc. ...

Mersana Therapeutics Appoints C. Boyd Clarke Chairman of the Board of Directors

...nce and commercial expertise in areas important to mersana at our stage of development. His skills complement...ng in their continued growth as Chairman." About mersana Therapeutics, Inc. Mersana, a privately held, ve...PureTech Ventures. Fleximer(R) is a trademark of mersana Therapeutics, Inc. ...